Chicago-based emerging medical device firm Advanced Cooling Therapy
(ACT) has closed a $1.5 million Series A financing round to support the
full commercial launch of its first product, the Esophageal Cooling
Device (ECD) to control patient temperature. ACT was a presenter in the WAN Investors’ Track at the 2013 Early Stage Symposium.
Read the full Business Wire story here.